[A new quinolone (pefloxacine) in bronchopulmonary superinfections in cystic fibrosis].
D000293:Adolescent; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015366:Pefloxacin; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000209:etiology
D000890:Anti-Infective Agents; D015366:Pefloxacin; D009268:Nalidixic Acid
Etude d'une nouvelle quinolone (pefloxacine) dans les surinfections bronchopulmonaires de la mucoviscidose.